Table 3: Liver parameters at the baseline in both studied groups (data reported as mean and standard deviation)
|
|
Placebo |
Combined nutraceutical |
|
Placebo |
Combined nutraceutical |
|
Aspartate transaminase (AST) |
39.2 (6.9) |
39.8 (7.2) |
Fatty Liver Index (FLI) |
87.5 (11.1) |
88 (8.9) |
|
Alanine transaminase (ALT) |
41.4 (9.7)
|
41.9 (10.3)
|
Hepatic Steatosis Index (HIS) |
31.6 (2.8) |
30.6 (3.1) |
|
gamma-Glutamyl Transferase |
44.2(13.6) |
44.9 (12.9)
|
Lipid Accumulation Product (LAP) |
84.1 (43.2) |
78.5 (50.1) |